PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
Clinical trial NCT05511922 · COMPLETED
Trial details
- NCT number
- NCT05511922
- Sponsor
- KalVista Pharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-24
- Primary completion
- 2026-05-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.